AI-generated analysis. Always verify with the original filing.
Cingulate Inc. completed the second closing of a $12 million private placement on February 13, 2026, issuing equity securities and appointing Jeff Hargroves to its Board of Directors and committees. The company also issued 25,786 shares of common stock to a lender on February 6, 2026, in exchange for debt.
Event Type
Disclosure
Mandatory
Variant
8-K
. Unregistered Sales of Equity Securities On February 6, 2026, Cingulate Inc. (the “ Company ”) issued 25,786 shares of the Company’s common stock, par value $0
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 1
and Exhibit 99.1 be incorporated by reference into the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly
. Other Events. On February 13, 2026, the Company completed the second and final portion of the Private Placement for gross proceeds of an additional $5.5 milli
. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press Release of Cingulate Inc., dated February 17, 2026 104 Cover Page Interact
Jeff Hargroves
Effective: 2026-02-13